1092563-27-3 |
4-溴-(2-甲氧基乙氧基)苯甲醚 |
4-Bromo-2-methoxy-1-(2-methoxyethoxy)benzene |
C10H13BrO3 |
1092563-41-1 |
3-甲基-4-(吡咯烷-1-基甲酰基)苯硼酸频哪醇酯 |
(2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)(pyrrolidin-1-yl)methanone |
C18H26BNO3 |
1092563-48-8 |
(2-氯-4-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)苯基)(吗啉)甲酮 |
(2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)(morpholino)methanone |
C17H23BClNO4 |
1092563-51-3 |
(4-Bromo-2-methylphenyl)-(4-ethylpiperazin-1-yl)-methanone |
(4-Bromo-2-methylphenyl)-(4-ethylpiperazin-1-yl)-methanone |
C14H19BrN2O |
1092563-60-4 |
n-[2-(二甲基氨基)乙基]-n-甲基-5-(4,4,5,5-四甲基-1,3,2-二噁硼烷-2-基)-2-吡啶羧酰胺 |
N-(2-(dimethylamino)ethyl)-N-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinamide |
C17H28BN3O3 |
1092563-66-0 |
1-[4-[4-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)-1H-吡唑-1-基]-1-哌啶基]-乙酮 |
1-(4-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRAZOL-1-YL)PIPERI |
C16H26BN3O3 |
1092563-68-2 |
1-(1-Boc-4-哌啶基)-3-甲基吡唑-4-硼酸频哪醇酯 |
1-(1-Boc-4-piperidyl)-3-methylpyrazole-4-boronic Acid Pinacol Ester |
C20H34BN3O4 |
1092563-72-8 |
tert-butyl 4-{[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}piperidine-1-carboxylate |
tert-butyl 4-{[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}piperidine-1-carboxylate |
C20H34BN3O4 |
1092563-73-9 |
|
1-Piperidinecarboxylic acid, 4-[3,5-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]-, 1,1-dimethylethyl ester |
C21H36BN3O4 |
1092563-82-0 |
8-溴喹噁啉-2(1h)-酮 |
8-BROMOQUINOXALIN-2(1H)-ONE |
C8H5BrN2O |
1092564-28-7 |
2-哌嗪酮,4-[5-(4,4,5,5-四甲基-1,3,2-二氧杂环戊硼烷-2-基)-2-吡啶基]- |
2-PIPERAZINONE, 4-[5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-2-PYRIDINYL] |
C15H22BN3O3 |
1092564-39-0 |
|
1-Piperidinecarboxylic acid, 4-(4-bromo-3,5-dimethyl-1H-pyrazol-1-yl)-, 1,1-dimethylethyl ester |
C15H24BrN3O2 |
1092566-65-8 |
3-(5-甲基-1,2,4-噁二唑-3-基)苯甲酸甲酯 |
Methyl 3-(5-Methyl-1,2,4-oxadiazol-3-yl)benzoate |
C11H10N2O3 |
1092568-83-6 |
|
(3-(5-methylpyrimidin-2-yl)phenyl)methanol |
C12H12N2O |
1092568-90-5 |
(3-(5-溴嘧啶-2-基)苯基)甲醇 |
[3-(5-bromopyrimidin-2-yl)phenyl]methanol |
C11H9BrN2O |
1092569-10-2 |
5-溴-3H-恶唑并[4,5-b]吡啶-2-酮 |
5-bromo-3H-[1,3]oxazolo[4,5-b]pyridin-2-one |
C6H3BrN2O2 |
1092569-13-5 |
|
Oxazolo[4,5-b]pyridin-2(3H)-one, 5-(trifluoromethyl) |
C7H3F3N2O2 |
1092569-14-6 |
|
Oxazolo[4,5-b]pyridine-5-carboxylic acid, 2,3-dihydro-2-oxo-, methyl ester |
C8H6N2O4 |
1092571-66-8 |
|
Phosphinous amide, P,P-bis(3,5-dimethylphenyl)-N,N-bis[(1S)-1-(2-naphthalenyl)ethyl] |
C40H40NP |
1092572-22-9 |
|
Pyrrolidine, 3-(3,5-difluorophenyl)-3-fluoro |
C10H10F3N |
1092573-86-8 |
3-(2,3-Dichlorophenyl)-3-pyrrolidinol |
|
C10H11Cl2NO |
1092574-87-2 |
3-cyclopentyl-1Н-indole |
3-cyclopentyl-1Н-indole |
C13H15N |
1092574-93-0 |
|
1H-Indole, 5-bromo-3-cyclohexyl |
C14H16BrN |
1092578-01-2 |
|
2-Propen-1-amine, N-[1-(4-bromophenyl)ethylidene]-, [N(E)] |
C11H12BrN |
1092578-05-6 |
|
(E)-N-(1-phenylethylidene)propan-1-amine |
C11H15N |
1092578-36-3 |
|
Carbamic acid, N-[(1R)-1-(hydroxymethyl)-2-methyl-2-propen-1-yl]-, 1,1-dimethylethyl ester |
C10H19NO3 |
1092578-44-3 |
Tofacitinib Impurity 20 |
Tofacitinib Impurity 20 |
C27H31N5O2S |
1092578-46-5 |
(3R,4S)-4-甲基-3-(甲基-7H-吡咯并[2,3-D]嘧啶-4-氨基)-BETA-氧代-1-哌啶丙腈 |
3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile |
|
1092578-47-6 |
(3S,4S)-4-甲基-3-(甲基-7H-吡咯并[2,3-D]嘧啶-4-氨基)-BETA-氧代-1-哌啶丙腈 |
(3S,4S)-Tofacitinib |
|
1092579-75-3 |
5-溴-4-氯-3-碘-1H-吡咯并[2,3-B]吡啶 |
5-BroMo-4-chloro-3-iodo-1H-pyrrolo[2,3-b]pyridine |
C7H3BrClIN2 |
1092579-78-6 |
5-溴-4-氯-3-碘-1H-吡唑并[3,4-b]吡啶 |
5-BROMO-4-CHLORO-3-IODO-1H-PYRAZOLO[3,4-B]PYRIDINE |
C6H2BrClIN3 |
1092579-95-7 |
5-溴-4-甲氧基-1H-吡咯并[2,3-B]吡啶 |
5-BroMo-4-Methoxy-1H-pyrrolo[2,3-b]pyridine |
C8H7BrN2O |
109258-59-5 |
BENZOIC ACID (4-HYDROXYIMINO-3-METHYL-CYCLOHEXA-2,5-DIENYLIDENE)-HYDRAZIDE |
BENZOIC ACID (4-HYDROXYIMINO-3-METHYL-CYCLOHEXA-2,5-DIENYLIDENE)-HYDRAZIDE |
C14H13N3O2 |
109258-71-1 |
AMINOLEVULINIC ACID RELATED COMPOUND B |
methyl 5-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-4-oxopentanoate |
C14H13NO5 |
1092580-01-2 |
1-[三(1-甲基乙基)硅基]-1H-吡咯并[2,3-B]吡啶-4-甲腈 |
1-[Tris(1-methylethyl)silyl]-1H-pyrrolo[2,3-b]pyridine-4-carbonitrile |
C17H25N3Si |
1092580-04-5 |
5-溴-4-碘-1H-吡咯并[2,3-B]吡啶 |
5-Bromo-4-iodo-1H-pyrrolo[2,3-b]pyridine |
C7H4BrIN2 |
1092580-91-0 |
5-溴-1H-吡咯并[2,3-B]吡啶-7-氧化物 |
1H-pyrrolo[2,3-b]pyridine, 5-bromo-, 7-oxide |
C7H5BrN2O |
1092582-89-2 |
(3AR,3A'R,8AS,8A'S)-2,2'-(戊烷-3,3-二基)双(8,8A-二氢-3AH-茚并[1,2-D]恶唑) |
8H-Indeno[1,2-d]oxazole, 2,2'-(1-ethylpropylidene)bis[3a,8a-dihydro-, (3aR,3'aR,8aS,8'aS) |
C25H26N2O2 |
1092585-67-5 |
|
Methanediol, 1-(2,6-dimethoxyphenyl)-, 1,1-diacetate |
C13H16O6 |
109261-24-7 |
2-(1,3-BENZODIOXOL-5-YL)-5-CHLORO-1H-BENZIMIDAZOLE |
2-(1,3-Benzodioxol-5-yl)-5-chlorobenzimidazole, 95% |
C14H9ClN2O2 |
109264-21-3 |
|
FIKTURVKRGQNQD-VHEBQXMUSA-N |
C20H38O2 |
1092649-16-5 |
|
4-(2-AMINOETHYL)-CIS-2,6-DIMETHYLMORPHOLINE |
C8H18N2O |
1092649-51-8 |
|
3-AMINO-3-(2-FLUOROPHENYL)-2,2-DIMETHYLPROPANOIC ACID |
C11H14FNO2 |
1092655-30-5 |
Trihexyltetradecylphosphonium bis(2-ethylhexyl)phosphate |
|
|
1092655-64-5 |
|
Pyridine, 2-(chloromethyl)-6-(1-methylethyl) |
C9H12ClN |
1092658-06-4 |
恩妥昔单抗 |
Ensituximab |
|
1092659-63-6 |
2-(4-(三氟甲基)苯基)噻唑烷-4-羧酸 |
2-[4-(trifluoromethyl)phenyl]-1,3-thiazolidine-4-carboxylic acid |
C11H10F3NO2S |
1092660-12-2 |
2-amino-2-phenyl-N-propylacetamide |
2-amino-2-phenyl-N-propylacetamide |
C11 H16 N2 O |
1092679-51-0 |
WAY100635 |
WAY100635 |
C29H38N4O6 |
1092682-52-4 |
|
1H-Pyrrole, 1-(4-fluorobutyl) |
C8H12FN |